Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jan;19(1):e9-e11.
doi: 10.1016/j.clml.2018.10.002. Epub 2018 Oct 13.

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Kristine A Frerichs  1 , Patricia W C Bosman  1 , Inger S Nijhof  1 , Sonja Zweegman  1 , Niels W C J van de Donk  2
Affiliations
Case Reports

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

Kristine A Frerichs et al. Clin Lymphoma Myeloma Leuk. 2019 Jan.
No abstract available

Keywords: CD38 antibodies; CMV; Infectious complication; Plasma cell dyscrasia; Viral infection.

PubMed Disclaimer

References

    1. Ljungman P., Boeckh M., Hirsch H.H. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87–91. - PubMed
    1. Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018;7:1–16. - PMC - PubMed
    1. Marchesi F., Pimpinelli F., Ensoli F., Mengarelli A. Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematol Oncol. 2018;36:381–391. - PubMed
    1. Drylewicz J., Schellens I.M., Gaiser R. Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation. J Transl Med. 2016;14:230. - PMC - PubMed
    1. Schutt P., Brandhorst D., Stellberg W. Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leuk Lymphoma. 2006;47:1570–1582. - PubMed

Publication types